WHC is still in active development. Read this to understand our approach.
depiction of WGQKYBSKWIADBV-UHFFFAOYSA-N.svg
isomerdesign

Benzylamine

Verificar en isomerdesign

pubchem

Benzylamine

Verificar en pubchem

drugmap

Benzylamine

Verificar en drugmap

Data

InChI: InChI=1S/C7H9N/c8-6-7-4-2-1-3-5-7/h1-5H,6,8H2

Sinónimos: benzylarnine,HSDB 2795,1-phenylmethanamine,alpha-Aminotoluene,SCHEMBL373, EINECS 202-854-1,bezylamine, Phenylmethylamine,QuadraPure BZA, 400-1100 micron,MFCD00008106, alpha-Aminotoluene, 1utn,BRN 0741984,2bza,Benzylamine, for GC derivatization, >=99.0%,TETRACYCLOHEXYLORTHOSILICATE,TOLUENE,ALPHA-AMINO,.alpha.-Aminotoluene,Benzylamine on polystyrene,CHEBI:40538,MFCD00145849,EINECS 202-854-1,benzyl amine,BRD-K76133116-001-01-2,Poly(styrene-divinylbenzene), aminomethylated, 1% cross-linked, 100-200 mesh,Benzenemethanamine, 9CI,NSC 8046, benzyl-amine, Benzenemethanamine,QuadraPure(TM) Benzylamine,89551-24-6, phenylmethanamine,Benzylamine, reagent grade,Epitope ID:141489,FT-0622834,Benzylamine,(Aminomethyl)benzene,EC 202-854-1,BENZYLAMINE [HSDB],phenylmethanamine,NSC8046, (Aminomethyl)benzene,BENZYLAMINE [MI], A1O31ROR09,STL115534,CHEMBL522,N-(phenylmethyl)amine,1-Phenylmethanamine,Moringine, UNII-A1O31ROR09,Tox21_300933,B0406,Aminomethyl polystyrene resin cross-linked with 1% DVB (200-400mesh) (2.0-3.0mmol/g),NCIOpen2_007746,Aminomethyl polystyrene (160-200 ?m, 0.8-1.3 mmol/g),A1O31ROR09, HSDB 2795,DSSTox_RID_76359,Aminotoluene,Monobenzylamine,ZINC6096244,STR00195,LACOSAMIDE IMPURITY J [EP IMPURITY],Sumine 2005, N-Benzylamine, Sumine 2006, a-Aminotoluene,CAS-100-46-9,3F830B2A-ABAA-4E26-971C-53B1C7485954, Moringine,benzyl-amine, MFCD00008106,FT-0622836, CHEMBL522,MFCD00135579,Phenylmethylamine,1utn,Sumine 2006,MFCD08561140,NH2Bn, CHEBI:40538,BENZYLAMINE, NSC 8046,MFCD00130502,Benzylamine, ReagentPlus(R), 99%,a-Aminotoluene,1utj, Sumine 2005, 1utj,ABN,QuadraPure(R) BZA, 400-1100 mum, extent of labeling: 20 mg/g loading, macroporous, 1-phenylmethanamine,.omega.-Aminotoluene,Q424000, Monobenzylamine,AKOS000119096,Benzylamine, analytical standard, 100-46-9,NCGC00254835-01,100-46-9,QuadraPure(TM) BZA,Benzenemethanamine,BnNH2,Benzylamine, purified by redistillation, >=99.5%, .alpha.-Aminotoluene,EN300-16215,NCGC00166029-01,UNII-A1O31ROR09, .omega.-Aminotoluene, BRN 0741984,4-12-00-02155 (Beilstein Handbook Reference),AI3-15299, (Phenylmethyl)amine,laquo Omegaraquo -aminotoluene, benzyl amine,DSSTox_CID_1839, AI3-15299,N-Benzylamine, TOLUENE,ALPHA-AMINO,NCGC00166029-02,DSSTox_GSID_21839,F2190-0388, BENZYLAMINE, omega-Aminotoluene,NSC-8046,Bzl-NH2, 2bza,(Phenylmethyl)amine,aminomethylbenzene,omega-Aminotoluene,DTXSID5021839,DB02464,BDBM10999,Aminomethyl polystyrene (rigid, macroporous 200-400?m, 2-3.5 mmol/g)

Estimated data

Solubilidad: -0.021 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 63.2% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.